In a tumor environment, tetranectin seems to be consumed for the proteolytic activity which is required for tumor metastasis, this results in lesser amount of tetranectin in patients with metastasis compared to primary tumor [21]. The gene discussed is CLEC3B; the disease is neoplasm.